Summary: In this awards ceremony, we announce the first place, second place, and third place of the Hypothesis Prize edition of The Longevity Prize, including several honorable mentions!Â
Presenter Yuri Deigin Yuri Deigin, MBA is a biotech entrepreneur with a focus on early-stage translation of scientific breakthroughs into therapies. He has over a decade of drug discovery and development experience, and a track record of outlicensing products to Big Pharma. Summary: In the upcoming talk “Epigenetic Rejuvenation by In Vivo Partial Reprogramming: Past,… Continue reading Yuri Deigin | Epigenetic Rejuvenation by In Vivo Partial Reprogramming: Past, Present, and Future
Presenter Ana Maria Cuervo Dr. Ana Maria Cuervo obtained her M.D. and Ph.D. in Biochemistry and Molecular biology from the University of Valencia (Spain) in 1990 and 1994, respectively, and received postdoctoral training at Tufts University in Boston, MA. In 2002, she started her laboratory at Albert Einstein College of Medicine, where she is now… Continue reading Ana Maria Cuervo | Targeting Selective Autophagy in Aging and Age-related Diseases
Presenter Vadim Gladyshev Vadim Gladyshev is a Professor of Medicine at Harvard Medical School, Director of the Center for Redox Medicine at Brigham and Women’s Hospital, and Associate Member of the Broad Institute. Dr. Gladyshev’s lab focuses on studying aging, rejuvenation and lifespan control using a combination of experimental and computational approaches. He has published… Continue reading V. Gladyshev, M. Moqri, V.Sebastiano | Quantifying Aging
Presenter Reason, Fight Aging Reason is co-founder and CEO of Repair Biotechnologies. He has been an active angel investor in the longevity industry since its earliest days, with investments including Oisin Biotechnologies and Leucadia Therapeutics. He is a long-standing and well-connected patient advocate for aging research, involved in numerous fundraising and outreach initiatives conducted by… Continue reading Reason, Fight Aging | Towards Biotechnology to Finally Defeat Cholesterol
Presenter Joao Pedro de Magalhaes I am a scientist originally from Porto in Portugal but have lived in Belgium and in the US (Boston), and I’m also of Spanish ancestry. Following training at Harvard Medical School, I am now a Professor at the University of Birmingham in England. My lab studies aging and longevity using… Continue reading Joao Pedro de Magalhaes | The Scientific Quest for Immortality
Presenter Bryan Johnson, Kernel Bryan Johnson is founder & CEO of Kernel, creator of the world’s first mainstream non-invasive neuroimaging system; OS Fund, where he invested $100M in the predictable engineering of atoms, molecules, and organisms into companies now collectively valued over $6B; and Blueprint, an endeavor to achieve humanity and earth scale cooperation starting… Continue reading Bryan Johnson | Blueprint Rejuvenation Athlete
Presenter Matt Kaeberlein Dr. Matt Kaeberlein is the Chief Science Officer at Optispan Geroscience and a Professor of Laboratory Medicine and Pathology at the University of Washington (UW) School of Medicine, with Adjunct appointments in Genome Sciences and Oral Health Sciences. Dr. Kaeberlein’s research interests are… Summary: Age is the greatest risk factor for most… Continue reading Matt Kaeberlein | Companion Animals in Geroscience: Challenges and Opportunities
Presenter Diana Guallar, CiMus Diana holds a PhD in Cellular Biology by the University of Zaragoza (Spain). Her thesis was focused on the study of epigenetic regulation of endogenous retroviruses in embryonic pluripotent stem cells… Summary: Diana researches epitranscriptomics – the epigenetic modifications to RNA and the defining step between DNA and protein translation. Broadly… Continue reading Diana Guallar | Epitranscriptomics as Novel Players in Aging and Rejuvenation
Presenter Tony Wyss-Coray Tony Wyss-Coray is the D.H. Chen Distinguished Professor of Neurology and Neurological Sciences and the Director of the Phil and Penny Knight Initiative for Brain Resilience at Stanford University. His lab studies brain aging and… Summary: Age is the key driver for dementia. 70% of centenarians have some form of severe or… Continue reading Tony Wyss-Coray | Young Blood for Old Brains
